Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Observation × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Squamous Intraepithelial Lesions 1 Sezary Syndrome 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphedema of Face 1 Lung Neoplasms 1

Interventions

Radiotherapy 10 fludarabine phosphate 6 Cyclophosphamide 6 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 5 Cyclosporine 5 Whole-Body Irradiation 4 Surgical Procedures, Operative 4 Radiofrequency Ablation 4 Mycophenolic Acid 4 Melphalan 4 Drug Therapy 4 Cisplatin 4 Busulfan 4 Antilymphocyte Serum 4 Surveys and Questionnaires 3 Radiosurgery 3 Methotrexate 3 Injections 3 Cord Blood Stem Cell Transplantation 3 fludarabine 2 Vinblastine 2 Videotape Recording 2 Standard of Care 2 Procarbazine 2 Prednisolone 2 Practice Guidelines as Topic 2 Mastectomy 2 Lidocaine 2 Hepatectomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡